During the opening segment of this panel discussion about recent advances and pharmacoeconomic considerations in the clinical management of Castration-Resistant Prostate Cancer (CRPC), discussion ...
Christopher Sweeney, MBBS, provides an overview of castration-resistant prostate cancer (CRPC) and discusses criteria that clinicians consider when making decisions about treatment for patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback